Restricted Indications
Patients unable to receive conventional amphotericin B due to toxicity (see Use of Amphotericin B Lipid Products)
Certain severe fungal infections (ie, meningitis) in consultation with Infectious Diseases
Formal Infectious Diseases Consultation is Mandatory
Conventional amphotericin B may be prescribed until the lipid product is approved
